Skip to main content Back to Top
Advertisement

11/20/2024

Lisdexamfetamine Dimesylate Capsules

Products Affected - Description

    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 20 mg, bottle, 100 count, NDC 47781-0563-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 40 mg, bottle, 100 count, NDC 47781-0565-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 50 mg, bottle, 100 count, NDC 47781-0566-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 60 mg, bottle, 100 count, NDC 47781-0567-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 70 mg, bottle, 100 count, NDC 47781-0568-01
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 20 mg, bottle, 90 count, NDC 65162-0023-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 30 mg, bottle, 90 count, NDC 65162-0024-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 40 mg, bottle, 90 count, NDC 65162-0025-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 50 mg, bottle, 90 count, NDC 65162-0026-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 60 mg, bottle, 90 count, NDC 65162-0027-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 70 mg, bottle, 90 count, NDC 65162-0028-09
    • Lisdexamfetamine dimesylate oral capsule, Apotex, 10 mg, bottle, 100 count, NDC 60505-4739-01
    • Lisdexamfetamine dimesylate oral capsule, Apotex, 20 mg, bottle, 100 count, NDC 60505-4740-01
    • Lisdexamfetamine dimesylate oral capsule, Apotex, 30 mg, bottle, 100 count, NDC 60505-4741-01
    • Lisdexamfetamine dimesylate oral capsule, Apotex, 40 mg, bottle, 100 count, NDC 60505-4742-01
    • Lisdexamfetamine dimesylate oral capsule, Apotex, 50 mg, bottle, 100 count, NDC 60505-4743-01
    • Lisdexamfetamine dimesylate oral capsule, Apotex, 60 mg, bottle, 100 count, NDC 60505-4744-01
    • Lisdexamfetamine dimesylate oral capsule, Apotex, 70 mg, bottle, 100 count, NDC 60505-4745-01
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 20 mg, bottle, 100 count, NDC 00054-0370-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 30 mg, bottle, 100 count, NDC 00054-0371-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 40 mg, bottle, 100 count, NDC 00054-0372-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 50 mg, bottle, 100 count, NDC 00054-0373-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 60 mg, bottle, 100 count, NDC 00054-0374-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 70 mg, bottle, 100 count, NDC 00054-0375-25
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-4661-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 20 mg, bottle, 100 count, NDC 00527-4662-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 30 mg, bottle, 100 count, NDC 00527-4663-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 40 mg, bottle, 100 count, NDC 00527-4664-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 50 mg, bottle, 100 count, NDC 00527-4665-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 60 mg, bottle, 100 count, NDC 00527-4666-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 70 mg, bottle, 100 count, NDC 00527-4667-37
    • Lisdexamfetamine dimesylate oral capsule, Mallinckrodt, 10 mg, bottle, 100 count, NDC 00406-5111-01
    • Lisdexamfetamine dimesylate oral capsule, Mallinckrodt, 20 mg, bottle, 100 count, NDC 00406-5112-01
    • Lisdexamfetamine dimesylate oral capsule, Mallinckrodt, 30 mg, bottle, 100 count, NDC 00406-5113-01
    • Lisdexamfetamine dimesylate oral capsule, Mallinckrodt, 40 mg, bottle, 100 count, NDC 00406-5114-01
    • Lisdexamfetamine dimesylate oral capsule, Mallinckrodt, 50 mg, bottle, 100 count, NDC 00406-5115-01
    • Lisdexamfetamine dimesylate oral capsule, Mallinckrodt, 60 mg, bottle, 100 count, NDC 00406-5116-01
    • Lisdexamfetamine dimesylate oral capsule, Mallinckrodt, 70 mg, bottle, 100 count, NDC 00406-5117-01
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 10 mg, bottle, 90 count, NDC 00378-6854-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 20 mg, bottle, 90 count, NDC 00378-6855-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 30 mg, bottle, 90 count, NDC 00378-6856-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 40 mg, bottle, 90 count, NDC 00378-6857-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 50 mg, bottle, 90 count, NDC 00378-6858-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 60 mg, bottle, 90 count, NDC 00378-6859-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 70 mg, bottle, 90 count, NDC 00378-6860-77
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0163-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 40 mg, bottle, 100 count, NDC 42858-0164-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 50 mg, bottle, 100 count, NDC 42858-0165-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 70 mg, bottle, 100 count, NDC 42858-0167-01
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 10 mg, bottle, 100 count, NDC 43547-0602-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 20 mg, bottle, 100 count, NDC 43547-0603-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 30 mg, bottle, 100 count, NDC 43547-0604-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 40 mg, bottle, 100 count, NDC 43547-0605-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 50 mg, bottle, 100 count, NDC 43547-0606-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 60 mg, bottle, 100 count, NDC 43547-0607-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 70 mg, bottle, 100 count, NDC 43547-0608-10
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 10 mg, bottle, 100 count, NDC 57664-0046-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 20 mg, bottle, 100 count, NDC 57664-0047-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 30 mg, bottle, 100 count, NDC 57664-0048-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 40 mg, bottle, 100 count, NDC 57664-0049-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 50 mg, bottle, 100 count, NDC 57664-0050-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 60 mg, bottle, 100 count, NDC 57664-0051-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 70 mg, bottle, 100 count, NDC 57664-0052-88

Reason for the Shortage

    • Alvogen has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Amneal has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Apotex has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Hikma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Lannett has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Mallinckrodt has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Mylan (Viatris) has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Rhodes has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Solco has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Sun Pharma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Takeda has Vyvanse available.

Available Products

    • Vyvanse oral capsule, Takeda, 10 mg, bottle, 100 count, NDC 59417-0101-10
    • Vyvanse oral capsule, Takeda, 20 mg, bottle, 100 count, NDC 59417-0102-10
    • Vyvanse oral capsule, Takeda, 30 mg, bottle, 100 count, NDC 59417-0103-10
    • Vyvanse oral capsule, Takeda, 40 mg, bottle, 100 count, NDC 59417-0104-10
    • Vyvanse oral capsule, Takeda, 50 mg, bottle, 100 count, NDC 59417-0105-10
    • Vyvanse oral capsule, Takeda, 60 mg, bottle, 100 count, NDC 59417-0106-10
    • Vyvanse oral capsule, Takeda, 70 mg, bottle, 100 count, NDC 59417-0107-10
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 10 mg, bottle, 100 count, NDC 47781-0562-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 30 mg, bottle, 100 count, NDC 47781-0564-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 10 mg, bottle, 100 count, NDC 42858-0161-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 20 mg, bottle, 100 count, NDC 42858-0162-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 60 mg, bottle, 100 count, NDC 42858-0166-01

Estimated Resupply Dates

    • Alvogen has lisdexamfetamine 20 mg, 40 mg, 50 mg, 60 mg, and 70 mg capsules available in limited supply.
    • Amneal has lisdexamfetamine capsules on back order and the company cannot estimate a release date.
    • Apotex has all lisdexamfetamine capsules in limited supply.
    • Hikma has lisdexamfetamine 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg capsules on allocation.
    • Lannett has lisdexamfetamine 10 mg and 70 mg on back order and the company cannot estimate a release date. The 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg capsules are available in limited supply.
    • Mallinckrodt has lisdexamfetamine 10 mg and 20 mg capsules in limited supply. The 40 mg capsules are on back order and the company estimates a release date of February 2025. The 40 mg, 50 mg, and 60 mg capsules are on back order with an estimated release date of early-January 2025. The 70 mg capsules are on back order and the company cannot estimate a release date.
    • Mylan has all lisdexamfetamine presentations available in limited supply.
    • Rhodes has lisdexamfetamine 30 mg, 40 mg, 50 mg, and 70 mg capsules on intermittent back order and the company is releasing supplies as they become available.
    • Solco has all lisdexamfetamine capsules on allocation.
    • Sun Pharma has all lisdexamfetamine capsules in limited supply.

Safety

    • The CDC has issued a health advisory regarding potential disrupted access to care in patients taking prescription stimulant medications and possible increased risks for injury and overdose. The health advisory can be found at https://emergency.cdc.gov/han/2024/han00510.asp

Updated

Updated November 20, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 19, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT